NYSE:LLY

Eli Lilly Stock News

Healthcare > Drug Manufacturers - General

Buy LLY

*Your capital is at risk

$1,125.38

+42.15 (+3.89%)

At Close: Jun 04, 2026

Sen. John Boozman Purchases Shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO)

02:06am, Wednesday, 10'th Dec 2025

Senator John Boozman (R-Arkansas) recently bought shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO). In a filing disclosed on December 08th, the Senator disclosed that they had bought betwee

Sen. John Boozman Sells Goldman Sachs ActiveBeta Emerging Markets Equity ETF (NYSEARCA:GEM) Stock

02:06am, Wednesday, 10'th Dec 2025

Senator John Boozman (R-Arkansas) recently sold shares of Goldman Sachs ActiveBeta Emerging Markets Equity ETF (NYSEARCA:GEM). In a filing disclosed on December 08th, the Senator disclosed that they h

Market Today: Fed Cut Looms, Nvidia's China Shift, Target's SoHo Push, OpenAI Taps Slack CEO

05:34pm, Tuesday, 09'th Dec 2025

Stock News Fed set for âhawkish cut': Goldman Sachs (GS) and other Wall Street desks expect the Federal Reserve to deliver a third straight 25 bps rate cut wh

Eli Lilly to Build $6 Billion Alabama Plant as Part of U.S. Investment

03:59pm, Tuesday, 09'th Dec 2025

The site is the third of four new facilities in the U.S. that the pharmaceutical company plans to announce, Eli Lilly said.

Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push

03:34pm, Tuesday, 09'th Dec 2025

Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chain

Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs

03:30pm, Tuesday, 09'th Dec 2025

Eli Lilly said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill, orforglipron, and other drugs.

Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama

03:30pm, Tuesday, 09'th Dec 2025

Huntsville site will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly's oral GLP-1, orforglipron Company plans to create 3,450 manufacturing and construc

Prediction: This Surprising Growth Stock Will Reach -- and Stay in -- the Trillion-Dollar Club in 2026.

01:15pm, Tuesday, 09'th Dec 2025

This company is a leader in a market that may approach $100 billion in a few years. This player's key products are delivering billion-dollar revenue.

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

10:00am, Tuesday, 09'th Dec 2025

Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

5 Bold Predictions for the Stock Market in 2026

09:22am, Tuesday, 09'th Dec 2025

Here are some things I think are more likely to happen in 2026 than the experts seem to believe.

Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition

08:28am, Tuesday, 09'th Dec 2025

INDIANAPOLIS , Dec. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Adverum Biotechnologies, Inc. (NASDAQ: ADVM) today announced that the tender offer (the "Offer") by Flying Tigers Ac

Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL

07:30am, Tuesday, 09'th Dec 2025

The risk reduction observed in BRUIN CLL-313 is among the most compelling observed for a single agent BTK inhibitor in a front-line CLL study These data will be simultaneously published in the Journ

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by